AbbVie Pharmaceuticals S.A.
41-45 Marinou Antypa, 141 21 Neo Iraklio
01.11.2018AbbVie Receives European Commission Approval of VENCLYXTO®
For the treatment of patients with chronic Lymphocytic Leukemia
26.09.2018AbbVie announces $5 million donation to Family Reach to support children battling cancer
This gift will provide critical financial services, support programs and educational resources to families across the United States struggling with the financial burden of a child's cancer diagnosis
23.08.2018AbbVie announces $100 million donation to Ronald McDonald House Charities
To support hospitalized children and their families
24.07.2018AbbVie receives U.S. FDA approval of ORILISSA™
For the Management of Moderate to Severe Pain Associated with Endometriosis
21.06.20188,000 AbbVie Employees Volunteer Across Five Continents
During Fifth-Annual "Week of Possibilities"